| scholarly article | Q13442814 |
| P2093 | author name string | Feng Yan | |
| Chao Pan | |||
| Xiao-Min Wang | |||
| Quan-Ming Ma | |||
| P2860 | cites work | Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs | Q40092607 |
| Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein | Q40109392 | ||
| Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance | Q40253550 | ||
| Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells | Q40363338 | ||
| Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors | Q41647860 | ||
| Signal transduction through MAP kinase cascades | Q41750250 | ||
| Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis | Q44527161 | ||
| High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells | Q46198386 | ||
| A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. | Q52828947 | ||
| Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. | Q52832264 | ||
| Reversal effect of specific inhibitors of extracellular-signal regulated protein kinase pathway on P-glycoprotein mediated vincristine resistance of L1210 cells. | Q53972104 | ||
| Hepatocellular carcinoma | Q93930900 | ||
| Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases | Q29614338 | ||
| Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity | Q29614981 | ||
| Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells | Q33358484 | ||
| Cellular mechanisms of multidrug resistance of tumor cells. | Q33854298 | ||
| Estimating the world cancer burden: Globocan 2000. | Q34518922 | ||
| Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer | Q34524629 | ||
| ABC multidrug transporters: structure, function and role in chemoresistance. | Q34586418 | ||
| Targeting senescence pathways to reverse drug resistance in cancer | Q36032220 | ||
| MAP kinase pathways: the first twenty years | Q36094669 | ||
| Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma | Q36445971 | ||
| New therapies for hepatocellular carcinoma. | Q36519041 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Cellular senescence and cancer treatment. | Q36616891 | ||
| Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs | Q39936488 | ||
| Calebin-A induces apoptosis and modulates MAPK family activity in drug resistant human gastric cancer cells | Q39962418 | ||
| Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives | Q39976096 | ||
| Targeting MDR1 gene: synthesis and cellular study of modified daunomycin-triplex-forming oligonucleotide conjugates able to inhibit gene expression in resistant cell lines. | Q40009019 | ||
| The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. | Q40056366 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 1443-1451 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells | |
| P478 | volume | 15 |
| Q38680790 | A 4-Phenoxyphenol Derivative Exerts Inhibitory Effects on Human Hepatocellular Carcinoma Cells through Regulating Autophagy and Apoptosis Accompanied by Downregulating α-Tubulin Expression. |
| Q36350221 | Chemosensitization of HepG2 cells by suppression of NF-κB/p65 gene transcription with specific-siRNA |
| Q36390281 | Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU |
| Q52718771 | Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer. |
| Q35894374 | Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma. |
| Q46873887 | IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling |
| Q39039916 | Involvement of CUL4A in regulation of multidrug resistance to P-gp substrate drugs in breast cancer cells. |
| Q41078238 | MAPK1 of Leishmania donovani modulates antimony susceptibility by downregulating P-glycoprotein efflux pumps |
| Q37802466 | Mitogen-activated protein kinases in hepatocellular carcinoma development |
| Q92838858 | p75NTR promotes survival of breast cancer resistant cells by regulating Bcl-2/Bax and MAPK pathway |
Search more.